First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment

by Daria V. Vasina, Denis A. Kleymenov, Victor A. Manuylov, Elena P. Mazunina, Egor Yu. Koptev, Elena A. Tukhovskaya, Arkady N. Murashev, Alexander L. Gintsburg, Vladimir A. Gushchin, Artem P. Tkachuk
Published 2019-11-01

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

by Artem P. Tkachuk, Evgeniia N. Bykonia, Liubov I. Popova, Denis A. Kleymenov, Maria A. Semashko, Vladimir P. Chulanov, Sergey B. Fitilev, Semyon L. Maksimov, Elena A. Smolyarchuk, Victor A. Manuylov, Daria V. Vasina, Vladimir A. Gushchin, Alexander L. Gintsburg
Published 2020-11-01